Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-301-2 | CAS number: 2110-78-3
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity study in rats (OECD Guideline 401): LD50 = 2,000-5,000 mg/kg in both males and females.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- High quality since a reliable study in accordance with OECD Guideline 401 is available.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Oral Acute Toxicity
The key oral acute toxicity study of methyl 2-hydroxybutyrate (KS_Acute toxicity: oral_rat_1993) was conducted in rats according to OECD Guideline 401.
Briefly, the test substance methyl 2-hydroxybutyrate was administered by gavage to male and female SD rats (SPF) to determine its lethal dose and evaluate its acute toxicity.
The LD50 was estimated to be 2,000-5,000 mg/kg in both males and females.
In the monitoring of general signs and symptoms, both males and females from the 5000 mg/kg group showed staggering gait 5-30 min after administration. Two males from this group died 10 min after administration after showing increased body muscle tone. Other males and females gradually showed sedation and body drooping, and some of them died within 24 hrs after showing collapse.
Both males and females from the 50-2000 mg/kg groups showed no changes in general symptoms. Body weight decreased in females from the 5000 mg/kg group 2 days after administration, but normal weight gains were observed thereafter. Males showed no abnormality. Necropsy revealed congestion and hemorrhage in the lungs and white color changes in the liver and duodenal mucosa in dead males and females, but surviving animals showed no particular abnormality at the end of the study.
Justification for classification or non-classification
Based on the LD50 range from >2000 - <= 5000 mg/kg bw determined in the acute oral toxicity study in rats the test item methyl 2-hydroxyisobutyrate was considered weakly toxic in rats. Therefore the test item does not meet the classification criteria of Regulation (EC) No 1272/2008 (CLP Regulation).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
